Clinical Trial Update: The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing rituximab for cognitive and hand function in secondary progressive multiple sclerosis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Cairo University | Conditions: Secondary Progressive Multiple Sclerosis (SPMS) | Phase 2 | Status: RECRUITING